Product Complaints and Adverse Reaction Handling: A Procedure Health Canada Inspectors Will Accept

Every licensed facility will receive a product complaint. A customer finds a chipped tablet, a pharmacist reports a label that does not match the carton, or a consumer says a natural health product made them unwell. What separates a compliant operation from one that collects an inspection observation is not whether complaints arrive. It is how quickly and how carefully each one is received, investigated, trended and, where needed, escalated to an adverse reaction report or a recall.

Health Canada inspectors read complaint files the way an auditor reads a bank statement. They look for a clear trail from the first phone call to the final decision, and they look for the judgment calls in between: was this a quality defect, a reportable adverse reaction, or both? This guide sets out a complaint and adverse reaction handling procedure that holds up under a Canadian good manufacturing practices (GMP) inspection, with the exact timelines, records and recall triggers that apply to drugs, natural health products and cannabis.

What Product Complaint Handling Means Under Canadian GMP

Product complaint handling is the documented GMP process for receiving, assessing, investigating and closing any complaint about a marketed product. In Canada it is anchored in the Food and Drug Regulations, Part C, Division 2. Section C.02.015 requires that the person in charge of the quality control department have any complaint or information about the quality of a drug, or its possible deficiencies or hazards, investigated, and ensure corrective action is taken when the matter relates to an activity the department controls. If it falls under a different quality control department, it must be forwarded to the person in charge there.

In practice this means a licensed fabricator, packager, labeller, tester, importer or distributor needs a written standard operating procedure that any employee can follow, a single intake point, and a quality unit that owns the decision. The same discipline applies to natural health product site licence holders under the Natural Health Products Regulations and to cannabis licence holders under the Cannabis Regulations. The regulator does not expect zero complaints. It expects every complaint to be visible, assessed and closed, with the reasoning written down. For how the quality unit's authority is scoped in a regulated facility, see our guide to the cannabis quality assurance person (QAP) duties.

Complaints, Quality Defects and Adverse Reactions: Know the Difference

A complaint is any communication that alleges a problem with a product. A quality defect is a complaint that points to a failure against a specification or GMP requirement, such as contamination, wrong count, or a packaging error. An adverse reaction is a harmful and unintended response to the product. One complaint can be all three at once. Getting the classification right in the first hours decides which regulatory clock starts and whether a recall assessment is needed.

Document the classification decision and who made it. Inspectors frequently cite files where a complaint was quietly closed as feedback when the description actually pointed to a potential adverse reaction or a quality defect.

The 15-Day Clock: Adverse Reaction Reporting for Drugs, NHPs and Cannabis

When a complaint describes harm, a reporting clock may start. Across drugs, natural health products and cannabis, serious adverse reactions must be reported to Health Canada within 15 days of the licence holder or manufacturer becoming aware of them. A serious reaction is one that results in death, is life-threatening, requires or prolongs hospitalization, causes persistent or significant disability, results in a congenital malformation, or is otherwise medically important. Each framework also requires an annual summary report.

Two points trip up licence holders. First, seriousness is driven by the outcome, not by whether the reporter and the company agree, and a reaction cannot be downgraded from serious once it meets the criteria. Second, for drugs there is a separate 72-hour obligation to inform Health Canada of certain foreign regulatory actions. When a complaint and an adverse reaction overlap, the adverse reaction report and the quality investigation proceed together, not one after the other.

A Complaint Handling Procedure Inspectors Will Accept

A defensible procedure moves a complaint through six stages: intake, triage, investigation, decision, action and closure, with trending running across all of them. Each stage has an owner, a timeline and a record. The goal is a file where an inspector can see what happened, who decided, why, and what changed as a result.

1. Intake and acknowledgement. Capture the complaint through a single, always-available channel, including after hours. Record the complainant, the date of first awareness, the product, the lot or batch number, the expiry, a verbatim description, and any mention of harm. Acknowledge receipt.
2. Triage and seriousness assessment. Within a defined short window, classify the complaint as a quality defect, an adverse reaction, both, or neither. If harm is alleged, assess seriousness and expectedness and start the 15-day reporting clock where it applies.
3. Investigation and root cause. Quarantine retained samples and affected lots. Investigate the cause with a structured method rather than a guess. Review batch records, testing data, and whether other lots or products share the cause.
4. Reportability and recall decision. Decide whether an adverse reaction report is due, and whether the marketed product may be unsafe or non-compliant, which triggers a recall assessment. Document the decision and the rationale, including any decision not to recall.
5. Corrective and preventive action (CAPA). Address the immediate issue and the systemic cause. Verify effectiveness. A corrective action that is never checked for effectiveness is a common inspection finding.
6. Closure and communication. Close the file with a clear conclusion, respond to the complainant where appropriate, and feed the outcome into trending and the annual product review.

Investigations that stop at the obvious symptom are the most common reason complaints recur. Our guide to root cause investigations that survive an inspection shows how to get past the symptom, and when a fix changes a validated process, manage it through formal change control.

When a Complaint Becomes a Recall

A complaint becomes a recall question the moment there is reason to believe a product already on the market does not conform to the Act or the Regulations, or presents a risk to health. Under the Food and Drug Regulations, every fabricator, packager, labeller, distributor, importer and wholesaler must maintain a control system that permits the complete and rapid recall of any lot on the market, section C.02.012. The recall decision flows directly from the complaint investigation.

Health Canada expects a written, pre-determined recall plan that names who initiates and coordinates the recall, can be executed at any hour, traces product including items in transit and professional samples, identifies and secures recalled stock, and ends with a reconciliation and final report. Where no real recall has occurred, the system must be tested with a mock recall that quality control reviews and approves. A recent example of a defect-driven recall is the cannabis pre-roll net content and count error, where a packaging and count issue would not have been caught by routine lab testing. Test your readiness before an inspector does with a mock recall simulation.

Complaint Trending: The Signal That Prevents the Next Recall

Trending is the analysis of complaints over time to find patterns that single investigations miss. A handful of apparently unrelated complaints can hide a drifting process, a failing supplier, or a packaging line that intermittently mislabels. Trending turns scattered complaints into an early warning, and it is a required input to the annual product quality review.

Trend by product, defect type, lot, line, supplier and root cause, not just by total count. Set alert thresholds so a rising category triggers a review before it becomes a recall. Feed trends into supplier qualification, so a vendor generating complaints is re-assessed, and into CAPA, so systemic fixes are tracked. Complaint handling is also one of the procedures facilities most often get wrong; see our list of the 10 SOPs every licensed facility gets wrong. A complaint system that produces numbers no one reviews is, to an inspector, no system at all.

Product Complaint Handling Compliance Checklist

Use this checklist to test your complaint and adverse reaction system against Health Canada expectations before your next inspection.

• A single, documented intake channel is available at all times, including after hours.
• Every complaint is logged with product, lot, expiry, first-awareness date and a verbatim description.
• A written SOP defines triage, seriousness assessment and classification within a set timeline.
• Adverse reaction seriousness and expectedness are assessed, and the 15-day clock starts at first awareness.
• Serious adverse reactions are reported to Health Canada within 15 days, and annual summary reports are prepared.
• Investigations use a structured root cause method and review whether other lots or products are affected.
• A documented recall assessment is completed for every potential quality defect, including a reasoned decision not to recall.
• CAPA is tracked to closure and verified for effectiveness.
• Complaints are trended by product, defect, lot, line, supplier and root cause, with alert thresholds.
• Trends feed the annual product quality review and supplier qualification, and complaint and recall records are retained per the applicable requirements.

Common Mistakes in Complaint and Adverse Reaction Handling

• Treating a complaint that alleges harm as routine feedback, so the 15-day clock never starts.
• Starting the reporting clock from the date the quality unit opened the file instead of first awareness anywhere in the company.
• Closing a complaint without a documented recall assessment, then being unable to show the decision not to recall was reasoned.
• Investigations that stop at the symptom, so the same defect returns.
• CAPA with no effectiveness check.
• No trending, or trending that counts complaints but never analyzes them by cause, lot, line or supplier.
• Assuming a contract manufacturer's complaints are their problem; the quality agreement must define who investigates and reports.

Frequently Asked Questions

How quickly must I report a serious adverse reaction in Canada?

Serious adverse reactions to drugs, natural health products and cannabis must be reported to Health Canada within 15 days of first becoming aware of them. For drugs, serious unexpected reactions occurring outside Canada are also reported within 15 days, and for natural health products the 15-day rule covers serious unexpected reactions whether they occur inside or outside Canada.

What is the difference between a complaint and an adverse reaction?

A complaint is any allegation of a problem with a product. An adverse reaction is a harmful and unintended response to the product. A complaint that describes harm is also an adverse reaction and may need an expedited report. A single complaint can be a quality defect and an adverse reaction at the same time, so both the quality investigation and the reporting assessment must run.

What must a complaint record contain?

At a minimum: the complainant and contact details where available, the date of first awareness, the product name, the lot or batch number and expiry, a verbatim description, the classification and who made it, the investigation and root cause, the reportability and recall decisions with rationale, the CAPA, and the closure. The file should let an inspector follow the complaint from intake to closure without asking questions.

When does a complaint require a recall?

When the investigation gives reason to believe that product already on the market does not conform to the Act or Regulations, or presents a risk to health. At that point the documented recall control system is activated. Even when the decision is not to recall, that decision and its rationale must be recorded.

Who is responsible for complaint handling in a licensed facility?

The quality unit owns the decision. Under the Food and Drug Regulations, the person in charge of the quality control department must have complaints about a drug's quality, deficiencies or hazards investigated and corrective action taken. For natural health products and cannabis, the quality assurance person and the licence holder carry equivalent accountability. Intake can be anyone, but the assessment and closure belong to quality.

Do we need a complaint procedure if we use a contract manufacturer?

Yes. Outsourcing an activity does not outsource the obligation. The written quality agreement must define how complaints and potential defects are shared, who investigates, who decides on recall and reporting, and how records flow between the parties. Inspectors expect both sides to be able to produce a consistent complaint history.

How MFLRC Can Help

MFLRC helps licensed drug, natural health product, cannabis, medical device, food and cosmetic businesses build complaint and adverse reaction systems that pass inspection. We draft and remediate complaint and recall SOPs, design seriousness and reportability decision trees, and build trending tools that feed the annual product review. Our quality assurance services and audit services give you root cause and CAPA support, mock recalls and inspection-readiness gap assessments, so you learn where a file is weak before an inspector does. Led by a security-cleared, Health Canada approved quality assurance person with more than twenty years across regulated sectors, MFLRC turns a scattered complaint log into a defensible quality system.

Want your complaint and recall procedures tested before an inspector does it for you? Book a complaint-handling gap assessment with MFLRC.

Conclusion

Complaints are not a sign of failure. They are the richest early-warning data a regulated business has. The organizations that stay out of trouble are the ones that receive every complaint the same disciplined way, decide seriousness and reportability fast, investigate to the real cause, and watch the trend. Build the procedure once, train to it, and keep the records clean. When the inspector opens your complaint file, the story should already be written.

Sources and References

• Health Canada, Good manufacturing practices guide for drug products (GUI-0001).
• Food and Drug Regulations, C.R.C., c. 870, section C.02.015 (quality control department) and C.02.012 (recall control system).
• Health Canada, Good pharmacovigilance practices guidelines (GUI-0102): The regulations (C.01.016 to C.01.019).
• Natural Health Products Regulations, SOR/2003-196, section 24 (adverse reaction reporting).
• Health Canada, Cannabis adverse reaction reporting for licence holders.
• Health Canada, MedEffect Canada, Report an adverse reaction to a drug: industry.